Loading patent…
AssigneeTeva Pharmaceutical Industries Ltd.
InventorsJoel Kaye, Nora Tarcic
Estimating the term…
This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject fampridine as an add-on therapy to or in combination with laquinimod. This invention also provides a package comprising laquinimod and fampridine for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides fampridine for use as an add-on therapy or in combination with laquinimod in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides a pharmaceutical composition comprising laquinimod and fampridine for use in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and fampridine in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome.
A method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising periodically administering to the subject an amount of laquinimod, and an amount of fampridine, wherein the amounts when taken together are effective to treat the subject.
(canceled)
(canceled)
10-17. (canceled)
19-28. (canceled)
30-43. (canceled)
(canceled)
A package comprising:
(canceled)
A pharmaceutical composition comprising an amount of laquinimod and an amount of fampridine wherein the laquinimod and the fampridine are prepared for simultaneous administration or contemporaneous administration.
55-74. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.